Genvoya and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Egrifta, and have Asthma.

The phase IV clinical study analyzes which people have Urticaria when taking Genvoya. It is created by eHealthMe based on reports of 13,480 people who have side effects when taking Genvoya from the FDA, and is updated regularly.

What is Genvoya?

Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,617 drugs and 2,953 conditions by eHealthMe. Check the latest studies of Urticaria.

On Jul, 27, 2026

13,480 people reported to have side effects when taking Genvoya.
Among them, 20 people (0.15%) have Urticaria.

Among these 20 people:

How long have people been on Genvoya when they have Urticaria? *

What is the gender of people who have Urticaria when taking Genvoya? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Urticaria when taking Genvoya? *

What are other drugs people take besides Genvoya? *

What are other side effects people have besides Urticaria? *

Rashes (redness): 7 people, 35.00%
Fatigue (feeling of tiredness): 4 people, 20.00%
Itching: 3 people, 15.00%
Injection Site Rash: 3 people, 15.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 15.00%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 2 people, 10.00%
Chronic Kidney Disease: 2 people, 10.00%
Decreased Activity: 2 people, 10.00%
Depression: 2 people, 10.00%
Dyspnea (difficult or laboured breathing): 2 people, 10.00%

What are the existing conditions these people have? *

Asthma: 3 people, 15.00%
Type 1 Diabetes: 2 people, 10.00%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 10.00%
Rash Macular (small, flat red spots): 2 people, 10.00%
Pain: 2 people, 10.00%
High Blood Pressure: 2 people, 10.00%
Rashes (redness): 1 person, 5.00%
Pneumonia: 1 person, 5.00%
Itching: 1 person, 5.00%
Acute Hiv Infection: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Genvoya and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Genvoya:

Genvoya (13,538 reports)

Urticaria treatments and more:

Urticaria (173,777 reports)

How severe was Urticaria and when was it recovered:

Urticaria in Genvoya

Expand to all the drugs that have ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate:

Urticaria and drugs with ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Genvoya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Urticaria (2,617 drugs)

Browse all the conditions that are associated with Urticaria:

Urticaria (2,953 conditions)

Related publications that referenced our studies

Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Genvoya) and Genvoya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.